Addex Therapeutics Ltd. (ADXN) Treasury Shares (2022 - 2024)

Addex Therapeutics' Treasury Shares history spans 3 years, with the latest figure at $992790.7 for Q4 2024.

  • For Q4 2024, Treasury Shares fell 3.18% year-over-year to $992790.7; the TTM value through Dec 2024 reached $992790.7, down 3.18%, while the annual FY2024 figure was $988598.4, 2.38% down from the prior year.
  • Treasury Shares for Q4 2024 was $992790.7 at Addex Therapeutics, down from $1.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $6.5 million in Q4 2022 and bottomed at $992790.7 in Q4 2024.
  • The 3-year median for Treasury Shares is $1.0 million (2023), against an average of $2.8 million.
  • The largest annual shift saw Treasury Shares tumbled 84.27% in 2023 before it decreased 3.18% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $6.5 million in 2022, then crashed by 84.27% to $1.0 million in 2023, then dropped by 3.18% to $992790.7 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Treasury Shares are $992790.7 (Q4 2024), $1.0 million (Q4 2023), and $6.5 million (Q4 2022).